Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a 13-Minute daily chat reduce burnout in future doctors and nurses?

NCT ID NCT07407413

Symptom relief Sponsor: Max Planck Social Neuroscience Lab Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests an 8-week online program where healthcare students pair up daily for a 13-minute guided conversation about emotions and gratitude. The goal is to see if this empathy- and compassion-based training improves mental health, resilience, social skills, and teamwork attitudes. About 360 students from a single university in Germany are participating, with half starting the training right away and the other half serving as a waitlist control group.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
empathy- and compassion-based socio-emotional mental training (EmCo) dyad intervention
What this could lead to
If it works, this could offer a simple, scalable online tool to reduce stress, burnout, and loneliness among healthcare students while boosting their resilience and teamwork skills.
What could go wrong
This is a relatively small, early-stage study (360 participants) testing a behavioral intervention, not a drug. Results may not generalize beyond this student population, and the benefits may be modest or short-lived.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 360 people

The number the study aims to enrol. It can still change while the study runs.

Started

Feb 2026

Expected to finish

Oct 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Between 18- and 65-years old. 2. actively enrolled student at the PMU. 3. Proficient in German. 4. Informed consent. 5. No symptoms of psychiatric disease within the past two years. 6. Stable internet access and necessary technical equipment (computer or laptop or tablet, and mobile phone with internet access). 7. No regular contemplative practice (≤ 50 hours total within the past six months); healthy population, non-clinical population. Exclusion Criteria: 8. Insufficient German proficiency. 9. Lack of stable internet access or required devices (computer or laptop or tablet, and mobile phone with internet access). 10. No informed consent. 11. Not actively enrolled at PMU. 12. Regular contemplative practice (\> 50 hours in the past six months (e.g., dyad, mindfulness, compassion-based practices). 13. Current psychiatric diagnosis or therapy, or reaching screening cutoffs on: * Patient Health Questionnaire-9 (PHQ-9; Martin et al., 2006; Löwe et al., 2004; Cutoff ≥ 10), * Generalized Anxiety Disorder-7 (GAD-7; Löwe et al., 2007; Spitzer et al., 2006; Cutoff ≥ 10), * Toronto Alexithymia Scale-20 (TAS-20; Bagby et al., 1994; Ritz \& Kannapin, 2000; Cutoff ≥ 61) * Standardized Assessment of Personality - Abbreviated Scale (SAPAS; Moran et al., 2003; Söchtig et al., 2012, Cutoff ≥ 4). * Moreover, participants endorsing suicidality on the PHQ-9 will be excluded.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Control (delayed training) condition are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Psychological Well-Being

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Control (delayed training) condition Intervention condition

Contacts and locations

Locations

  • Social Neuroscience Lab, Max Planck Society

    Berlin, Germany

More trials for these conditions

Other studies related to the condition(s) this trial covers.